Radiation to Treat Multiple Myeloma

An i3+3 Phase I Hypofractionation Trial for Multiple Myeloma

What's the purpose of the trial?

Doctors leading this study would like to see if a shorter radiation course (i.e., hypofractionation) for pelvic radiation is safe for multiple myeloma.

Trial status

Not yet accepting

Phase
Phase 1
Enrollment
30
Last Updated
2 weeks ago
Am I Eligible

Participating Centers

There is one center participating in this trial. Enter a location below to view the distance.

Experimental Treatments

Learn more about the experimental treatments being evaluated in this clinical trial.

  • Radiation

Arms / Cohorts

Explore eligibility, treatments and learn more about potential cohorts.

Not yet accepting

Group 1 - Dose Schedule 1

Not yet accepting

Group 2 - Dose Schedule 2

Not yet accepting

Group 3 - Dose Schedule 3

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.